ENTPD1 and neoplasm: In a recent study, in iCCA tumor sites, two immune subpopulations including immunosuppressive CD39+Foxp3+CD4+ Tregs and immune exhausted-like CD39+PD-1+CD8+ T cells were identified correlating with a worse clinical prognosis.